NYMOX PHARMACEUTICAL CORPORATION Adjustments For Depreciation And Amortisation Expense
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Adjustments For Depreciation And Amortisation Expense of $1.00 thousand for the 9-month period ending 2018-09-30, per its 6-K filed 2018-11-13.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense · last filed 2018-11-13
- 2018-09-30: Adjustments For Depreciation And Amortisation Expense 9 month $1.00K.
| Period end | Adjustments For Depreciation And Amortisation Expense 9 month |
|---|---|
| 2018-09-30 | $1.00K 6-K · filed 2018-11-13 |